3S34
Structure of the 1121B Fab fragment
Summary for 3S34
Entry DOI | 10.2210/pdb3s34/pdb |
Related | 3S36 3S37 |
Descriptor | 1121B Fab light chain, 1121B Fab heavy chain, PHOSPHATE ION, ... (4 entities in total) |
Functional Keywords | vegf receptor domain 3, immune system |
Biological source | Mus musculus, Homo sapiens (mouse, human) More |
Total number of polymer chains | 2 |
Total formula weight | 46664.93 |
Authors | Franklin, M.C. (deposition date: 2011-05-17, release date: 2011-08-24, Last modification date: 2024-10-09) |
Primary citation | Franklin, M.C.,Navarro, E.C.,Wang, Y.,Patel, S.,Singh, P.,Zhang, Y.,Persaud, K.,Bari, A.,Griffith, H.,Shen, L.,Balderes, P.,Kussie, P. The Structural Basis for the Function of Two Anti-VEGF Receptor 2 Antibodies. Structure, 19:1097-1107, 2011 Cited by PubMed Abstract: The anti-VEGF receptor 2 antibody IMC-1121B is a promising antiangiogenic drug being tested for treatment of breast and gastric cancer. We have determined the structure of the 1121B Fab fragment in complex with domain 3 of VEGFR2, as well as the structure of a different neutralizing anti-VEGFR2 antibody, 6.64, also in complex with VEGFR2 domain 3. The two Fab fragments bind at opposite ends of VEGFR2 domain 3; 1121B directly blocks VEGF binding, whereas 6.64 may prevent receptor dimerization by perturbing the domain 3:domain 4 interface. Mutagenesis reveals that residues essential for VEGF, 1121B, and 6.64 binding are nonoverlapping among the three contact patches. PubMed: 21827946DOI: 10.1016/j.str.2011.01.019 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.2 Å) |
Structure validation
Download full validation report
